the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

Piblisher (A-Z)

Category

Drug & Market Development Publications Report List

*Report
 
Expanding Opportunities in Contract Research and Contract Manufacture of Biotherapeutics/Biologics
Table of Contents Published: 2007/11
D&MD' s Expanding Opportunities in Contract Research and Contract Manufacture of Biotherapeutics/ Biologics market analysis report is a comprehensive compilation of CROs, CMOs and their numerous secondary interconnections. ...

Guide to Business Plan Writing, 2nd Edition
Table of Contents Published: 2007/11
D&MD' s Guide to Business Plan Writing, 3rd edition helps companies in the life sciences industry create an effective business plan for early and mid-stage stage business ventures. ...

Due Diligence in Life Science Transactions, 2nd Edition
Table of Contents Published: 2007/10
D&MD' s Guide to Due Diligence in Life Science Transactions, 2nd Edition provides a comprehensive overview on due diligence and a proven path to success for professionals working in the life sciences industry. ...

Guide to Good Clinical Practice, 3rd Edition
Table of Contents Published: 2007/09
D&MD' s Guide to Good Clinical Practice, 3rd Edition updates the regulations and their respective amendments since the 2nd edition was published in 2005. The guide details the duties of the sponsors, institutional review boards (IRB), investigators, and t ...

Guide to Good Facility Design, 2nd Edition
Table of Contents Published: 2007/08
Drug regulatory agencies require pharmaceutical and biopharmaceutical establishments to comply with Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) regulations. D&MD' s Guide to Good Facility Design, 2nd Edition examines these regulat ...

Guide to Good Laboratory Practice, 3rd Edition
Table of Contents Published: 2007/08
D&MD' s Guide to Good Laboratory Practice, 3rd Edition examines the GLP regulations in the United States and other countries in detail, and gives firm guidelines for compliance, using as a basis the GLP requirements published in the U.S.A Code of Federal ...

Guide to Good Validation Practice, 3rd Edition
Table of Contents Published: 2007/08
D&MD' s Guide to Good Validation Practice, 3rd Edition is devoted to considering in greater detail the ways of complying with validation requirements at all stages of drug research, development and manufacture. The particular problems associated with the ...

Prescription Drug Counterfeiting
Table of Contents Published: 2007/04
This report provides a unique examination and analysis of major global pharmaceutical markets, delivers a realistic description of counterfeiter capabilities, and covers new and emerging anti-counterfeiting technologies ...

Preparing the Common Technical Document (CTD) for CMC
Table of Contents Published: 2007/03
D&MD' s Preparing the Common Technical Document (CTD) for CMC provides a detailed description and analysis of the regulations, requirements and strategy for preparing a CTD. ...

Transdermal & Transmucosal Delivery of Therapeutics, 2nd Edition
Table of Contents Published: 2007/02
D&MD' s Transdermal & Transmucosal Delivery of Therapeutics, 2nd Edition market analysis report estimates the transdermal/transmucosal drug delivery market is poised for growth through 2010. This report highlights the technologies and drugs currently avai ...

Current Drug Development Market for Cytokines, Chemokines and Growth Factors
Table of Contents Published: 2007/01
This report succinctly details all the latest advances in the push to market of cytokine-based therapeutics: which products have evolved, which have failed and new players on the field. Primary readers will have comprehensive updates on relevant company p ...

Discovery to IND Filing, 2nd Edition
Table of Contents Published: 2007/01
This publication provides a review of the major steps as well as the current techniques utilized in the discovery to IND filing phase of new product innovation. ...

Market Opportunity in the G-Protein Coupled Receptors (GPCRs) Target Space: Qualitative and Quantitative Market Metrics
Table of Contents Published: 2007/01
D&MD' s Market Opportunity in the G-Protein Coupled Receptors (GPCRs) Target Space: Qualitative and Quantitative Market Metrics is a focused market analysis report that provides the latest analysis of the GPCR target space in terms of druggable targets av ...

Commercial Opportunities for Enzyme Technologies, 3rd Edition
Table of Contents Published: 2006/11
This report provides the research about Commercial Opportunities for Enzyme Technologies Market. ...

Molecular Diagnostics: Effective Tools for Disease Management, 3rd Edition
Table of Contents Published: 2006/11
Effective Tools for Disease Management, 3rd Edition market analysis report offers a comprehensive coverage of the scientific and technological developments which are creating new opportunities for the development of improved molecular diagnostics. ...

Novel Targets in Drug Discovery
Table of Contents Published: 2006/11
D&MD's Novel Targets in Drug Discovery report provides an overview of the concept of drug targets, and discusses their place in modern drug discovery. The report looks at the role of technologies such as genomics, proteomics and bioinformatics in target i ...

Antibody Therapeutics: Product Development, Market Trends, and Strategic Issues, Revised Edition
Table of Contents Published: 2006/10
D&MD's Antibody Therapeutics market analysis report provides an update of the current market environment including clinical study status, progresses made in the area of collaborations and partnerships, patent situation, and finally the market status. ...

Impact of Nano Materials in Drug Delivery & Human Tissue Engineering
Table of Contents Published: 2006/10
This report provides a market driven top down approach that identifies existing products using nano based knowledge to strengthen their capabilities and provides a description of the product' s market niche to pinpoint future trends. ...

Kinases: Advanced Strategies and Multiple Targets for Drug Discovery
Table of Contents Published: 2006/09
D&MD's Kinases: Advanced Strategies for Drug Discovery market analysis report comprehensively reviews protein kinases and assesses their importance as drug targets. Approaches to kinase drug discovery are evolving. Small molecule inhibitors now encompass ...

Ion Channels and G Protein-coupled Receptors (GPCRs) Qualitative and Quantitative Analysis
Table of Contents Published: 2006/08
This report focuses on two key pharmaceutical target classes-GPCRs and Ion Channels. ...

Managing Toxicology for the Future: Improving Predictive Power Through Integrated Technologies, 2nd Edition
Table of Contents Published: 2006/08
This report provides the research about Managing Toxicology Market ...

The Bioprocessing Industry: Increasing Capacity, Production, and Efficiency, 2nd Edition
Table of Contents Published: 2006/08
This report covers the most important issues in bioprocessing including the threat of a significant shortage in manufacturing capacity, consolidation in key sectors of the industry and the next drug discovery trends fueling expansion. ...

High Growth Diagnostics: Technology and Market Analyses
Table of Contents Published: 2006/07
Technology and Market Analyses of Segments experiencing Robust Growth in the Various Diagnostics Spaces market analysis report focuses on the market segments within the diagnostics industry that are currently experiencing robust growth. ...

Pain Therapeutics: New Times, New Targets
Table of Contents Published: 2006/07
The report provides a background on pain, current therapies and research and development in the area. ...

A Guide to Business and Regulatory Strategies for Companion Diagnostics and Individual Therapies
Table of Contents Published: 2006/06
This report is a unique compilation of historical companion diagnostic products, business models for drug/diagnostic collaborations, education & marketing, intellectual property, regulatory, and reimbursement information for those interested in developing ...

Biodisposables: Utility and Technological Advances
Table of Contents Published: 2006/06
D&MD's Growth and Technological Advances of the Biodisposables Market is valuable tool. ...

COPD Drug Discovery How New Generation Therapies Seek to Target Underlying Disease
Published: 2006/06
Chronic Obstructive Pulmonary Disease (COPD) has been a much neglected area in drug development for several decades but now is the fifth leading cause of death worldwide. ...

D&MD's Peptides 2006: New Applications in Discovery, Manufacturing, and Therapeutics
Table of Contents Published: 2006/06
To date, three types of molecules have been developed for the treatment of human diseases. ...

Developing and Managing Successful Bio-Outsourcing Relationships
Table of Contents Published: 2006/03
The bio-outsourcing trend is being influenced by recent developments such as dwindling biopharmaceutical financial support, increasing costs associated with building biomanufacturing facilities ...

High Content Screening (HCS): An Industry Analysis
Table of Contents Published: 2006/03
An Industry Analysis is focused on an emerging and key segment of the life science tools and technology space-high content analysis. ...

Breast Cancer Therapeutics: How Innovation is Shaping Future Therapies
Table of Contents Published: 2006/01
reast cancer is a complex heterogeneous disease characterized by uncontrolled growth and spread of abnormal cells. It is also very prevalent, with reports from the World Health Organization estimating that more than 1.2 million people will be diagnosed wi ...

Cell Therapy Commercialization Applying Stem Cell and Related Strategies
Table of Contents Published: 2006/01
Traditionally, treatment of human diseases is carried out by small molecular weight pharmaceuticals or large biotherapeutic molecules that modulate the biology of specific cell types. ...

How to Succeed In Personalized Medicine by Using Tools and Technologies Which Companies and Technologies are Profiting From a Favorable Regulatory Environment
Table of Contents Published: 2006/01
The focus of pharmacogenomics is currently selecting targets that are validated from a genetics perspective before looking into the entire genome, attacking attrition early in development (Phase I and II), addressing adverse reactions in Phase III, and su ...

Bioprocesses of Biopharmaceuticals: The Obligatory Role of Post Translational Modifications to Create Functional Bioactive Molecules
Table of Contents Published: 2005/12
The growing demands for existing biologics production are reflected in biopharmaceutical sales figures: The top 15 products in 2004 posted revenues of $38 billion. Although biologics manufacturing now is focused chiefly on a small number of blockbuster pr ...

Market Opportunities and Challenges for Antibody Arrays and Beads: A Market Research Study
Table of Contents Published: 2005/11
More than 100 companies are developing or have developed antibody array and/or bead platforms. ...

Organic and Medicinal Chemistry in Drug Discovery: Pharma's Intelligent Design
Table of Contents Published: 2005/11
D&MD's Organic and Medicinal Chemistry in Drug Discovery Report analyzes the methods and technologies currently used to craft compound collections as well as the products and services available in support of pharma's chemistry programs. ...

ADME in Children and The Elderly: Clinical Challenges and Opportunities
Table of Contents Published: 2005/10
ADME is the key for ensuring efficacy and tolerability. However, many drugs still fail due to poor ADME. This report examines the latest research on the causes and consequences of ADME changes in the elderly and children ...

hERG: Technology and Market Analysis
Table of Contents Published: 2005/10
D&MD' s hERG: Technology and Market Analysis Report is the only syndicated report that comprehensively addresses the hERG market landscape. The Report details the physiology and biology of hERG as well as its role in drug toxicity. ...

Patents in the Postgenomic Era: Proprietary Drug Targets and Therapies
Table of Contents Published: 2005/10
By 2001, the United States Patent and Trademark Office (USPTO) received 34,527 biotechnology patent applications. ...

Mammalian Cell Culture: Production Technologies and Market Overview
Table of Contents Published: 2005/09
This report presents an analysis of currently used techniques in the production of marketed products by mammalian cell culture systems. ...

Drug Targets from Genomics: Evolving Tools for Discovery
Table of Contents Published: 2005/08
This Report analyzes current and projected revenues from sales of omic technology-based products (reagents and consumables), which in 2004 totaled nearly $1.5 billion. ...

The Bioprocess Report: Trends in Biopharmaceutical Manufacturing Technology
Table of Contents Published: 2005/07
The Bioprocess Report represents a breakthrough for the biopharmaceutical industry. It is a comprehensive repository of invaluable information summarizing current and future technologies that have application in the production of biopharmaceutical product ...

Gene Therapy: Current Status and Prospects
Table of Contents Published: 2005/06
This Report provides a detailed breakdown of the applications and markets for gene therapy as well as an analysis of future growth trends. ...

Model Organisms in Drug Discovery and Development: An Industry Analysis
Table of Contents Published: 2005/06
The Report provides comparisons of the various model organisms being deployed currently by the pharmaceutical and biotechnology companies ...

Angiogenesis Modulators: Strategies for Drug Discovery
Table of Contents Published: 2005/05
D&MD's Angiogenesis Modulators: Strategies for Drug Discovery Report provides an up-to-date assessment of current directions and prospects in the angiogenesis modulators field. ...

Rapid Viral Testing
Table of Contents Published: 2005/04
Receive a thorough overview of the evolving field of rapid viral testing with D&MD's Rapid Viral Testing Report, including market forecasts through 2010. ...

Therapeutic Vaccines for Cancer: On the Threshold of Success
Table of Contents Published: 2005/04
This Report provides a comprehensive analysis of therapeutics currently in development, as well as those that have been discontinued. ...

G-Protein Coupled Receptors (GPCRs): Technical Overview, Emerging Technologies, Market Trends & Opportunities, 2nd Edition
Table of Contents Published: 2005/03
G Protein-Coupled Receptors (GPCRs) account for 50% of the current drug targets, and remain about one-third of the drug discovery effort in the drug discovery-development community. ...

Post-Genomic Biomarkers: Revolutionizing Drug Development and Diagnostics 2nd Edition
Table of Contents Published: 2005/03
The first edition of D&MD Publications' report, covering post-genomic biomarkers, was published in September 2003. ...

Strategies and Tactics thatImprove Patient Recruitment and Retention in Clinical Studies
Table of Contents Published: 2005/03
Patient recruitment and retention currently represents a critical bottleneck in clinical research and drug development. ...

Prions: A Primer for the Biopharmaceutical Industry
Table of Contents Published: 2005/02
Transmissible spongiform encephalopathy (TSE) agents, or prions as they are commonly referred to, are a significant concern to the biologicals and biotechnology industries. ...

Solving Drug Discovery with Metabolomics and Metabonomics: New Aspects of the "Omic" Revolution
Table of Contents Published: 2005/02
This Report will analyze the biochemical nature of metabolomics, the technologies behind metabolomics, metabonomics related approaches, and the appropriate market potentials. ...

Proteases as Drug Targets: Technologies and Opportunities for Drug Discovery
Table of Contents Published: 2005/01
Proteases are a superfamily of enzymes with important roles in the regulation of cellular protein activity. There are at least 475 known and putative proteases and 103 homologs to known proteases in humans, and it is estimated that up to 1,200 human genes ...

Protein-Protein Interactions as Drug Targets: Focusing on Cell Circuitry
Table of Contents Published: 2005/01
The area of protein-protein interaction has been growing at a tremendous rate. The market is expected to reach over $50 billion by year 2010. ...

RNAi: Broad Application, Expansive Opportunity, 2nd Edition
Table of Contents Published: 2005/01
The drug discovery market based on RNAi is projected to be $650 million in 2005 and $1 billion by 2010. Don't miss out on your share of this growing market! ...

Cardiovascular Disease Current Research, Devices, and Drugs
Table of Contents Published: 2004/11
This Report analyzes the pathology and rationale behind CVD risk reduction through a review of recently discovered genetic influences as well as a review of comorbid risk factors. It provides valuable market insight into improving CVD clinical trial desig ...

Structure-Guided Drug Design Rediscovering the Importance of Drug Structure for Drug Discovery
Table of Contents Published: 2004/11
This Report describes the many advances including crystallography and informatics that are behind these successes. The Report also discusses the impact these advances in structure-based drug design are likely to have on the economics of drug discovery. ...

Fluorescent Proteins Technologies, Applications, and Opportunities for Drug Discovery
Table of Contents Published: 2004/08
Fluorescent proteins are fast providing novel insights into compound-induced responses in drug discovery. This is taking place from two key vantage points, namely, in real time and in living systems. ...

Chemical Genomics Commercial Applications in Drug Discovery and Development
Table of Contents Published: 2004/07
D&MD's Chemical Genomics Report provides an in-depth analysis of the promising market for chemical genomics and chemogenomics. ...

Systems Biology Key to Unlocking the Value within the Omics Revolution
Table of Contents Published: 2004/01
This Report describes the current state and future prospects of the rapidly developing systems biology field. ...

Cytokines, Chemokines, and Growth Factors Key Targets for Immunotherapeutic Development
Table of Contents Published: 2003/11
The increased market penetration of approved drugs targeting cytokines and their receptors has spurred several pharmaceutical companies to devote a portion of their pipelines to the development of these immunotherapeutics. ...

Lead Optimization A Reinvention of the Process
Table of Contents Published: 2003/11
This report examines in detail how to successfully integrate intelligent lead optimization library design and synthesis, advanced screening technologies, and early involvement of in vivo testing. ...

Ion Channels Technology Advances Driving Commercial Opportunities
Table of Contents Published: 2003/09
This is the only publication focused solely on the commercial interest in ion channels technologies. This Report is essential reading for those decision-makers in the pharmaceutical, biotechnology, and drug discovery industries. ...

Protein Arrays
Table of Contents Published: 2003/06
This report will allow you to assess the market potential and opportunity gaps for high density arrays, primarily used for proteome wide analysis, verses low density arrays used principally for protein marker analysis. ...

Cell-Based Assays: Commercial Opportunities, Legal Trends, & Technology Analyses
Table of Contents Published: 2003/04
This comprehensive Report provides an overview of the industry, qualitative analysis of the market, and a quantitative examination of the market opportunity (in various sub-sectors of cell-based assays). We also examine the intellectual property issues im ...

*Top


US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.